Company profile: Axon Therapies
1.1 - Company Overview
Company description
- Provider of neuromodulation-based heart failure solutions, including SAVM (Splanchnic Ablation for Volume Management), a procedure that ablates the right greater splanchnic nerve to reduce sympathetic activity, normalize volume balance, and improve heart function in HFpEF; the catheter-based Axon Ablation System delivering targeted ablation via the femoral vein; and Rebalance-HF studies evaluating SAVM safety and efficacy.
Products and services
- Axon Ablation System: A catheter-based system that delivers targeted ablation to the right greater splanchnic nerve via femoral vein access, enabling precise execution of the SAVM procedure
- SAVM (Splanchnic Ablation for Volume Management): A neuromodulation-based procedure that ablates the right greater splanchnic nerve to reduce sympathetic activity, normalize volume balance, and improve heart function in HFpEF patients
- Rebalance-HF Clinical Studies: Trial-based evaluations assessing safety and efficacy of SAVM, featuring responder analysis and primary results from the REBALANCE-HF trial to quantify therapeutic benefit
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Axon Therapies
Roxwood Medical
HQ: United States
Website
- Description: Provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease, offering solutions in interventional cardiology, endovascular therapy, PCI, and critical limb ischemia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Roxwood Medical company profile →
Minvasys
HQ: France
Website
- Description: Provider of solutions for the treatment of cardiovascular disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Minvasys company profile →
Xenios
HQ: Germany
Website
- Description: Provider of extracorporeal therapy systems delivering minimally invasive disposable lung and heart therapies on a single platform, including the Xenios Console for ECLS in heart and lung failure; MultiSupport GROUND for ground transport requiring extracorporeal gas exchange or circulatory support; Novalung Kits with integrated pressure sensors for blood gas exchange; and iLA activve Kits for gas exchange and temperature control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xenios company profile →
Berlin Heals
HQ: Germany
Website
- Description: Provider of implantable medical devices for the treatment of heart failure, including the C-MIC Device, which delivers a constant, minimal electrical direct current to the heart to promote reverse remodeling of cardiac muscle tissue in heart failure patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Berlin Heals company profile →
Cleveland HeartLab
HQ: United States
Website
- Description: Provider of specialty clinical laboratory and disease management services focused on novel biomarker technologies and proprietary cardiovascular diagnostic tests, including inflammation testing, Cardio IQ lipid particle analysis, genetic and metabolic testing, and cardiovascular disease management, plus biomarker development R&D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cleveland HeartLab company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Axon Therapies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Axon Therapies
2.2 - Growth funds investing in similar companies to Axon Therapies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Axon Therapies
4.2 - Public trading comparable groups for Axon Therapies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →